Gurnet Point Capital

Investor type Hedge Fund


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 13
Average round size
The average size of a deal this fund participated in
Portfolio companies 9
Rounds per year 1.62
Lead investments 1
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 2
Key employees Soon

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Life Science
  • Health Care
  • Therapeutics

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Gurnet Point Capital:
Typical Co-investors
Gurnet Point Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Gurnet Point Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
African Rainbow Capital Gauteng, NA - South Africa, South Africa
Aijian Zhengquan China, Shanghai
Colfax Creek Birmingham, Michigan, United States
FRONTIER Japan Japan, Tokyo
Guangzhou Yuexiu Financial Holdings China, Guangdong, Guangzhou
Journey Growth -
Leshi Zhile Keji Beijing, Beijing, China
Lorem Partners Alberta, Calgary, Canada
Media Ventures Cologne, Germany, Nordrhein-Westfalen
Mediterranean Towers Ventures Finland, Kouvola, Kymenlaakso
Neva Finventures Italy, Piemonte, Turin
NHN Entertainment Corp Kyonggi-do, Seongnam, South Korea
Plutus Capital New York, New York, United States
PriceDekho India, Jaipur, Rajasthan
River Head Capital Chaoyang, China, Liaoning
Rongsheng Huitong Beijing, China, Pinggu
Sowefund France, Ile-de-France, Paris
Table Mountain Ventures New York, New York, United States
Takamul Capital -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Mahana Therapeutics

Information Technology
$61M11 Aug 2021 San Francisco, California, United States


Health Care
15 Dec 2020 Massachusetts, United States

Zikani Therapeutics

Life Science
$7M20 Apr 2020 Newton, Massachusetts, United States

Alladapt Immunotherapeutics

$60M20 Feb 2020 California, United States


Life Science
$59M01 Nov 2018 United States, Cambridge

Zikani Therapeutics

Life Science
$20M02 Apr 2018 Newton, Massachusetts, United States


Consumer Goods
Health Care
$35M20 Mar 2017 California, United States

Crossover Health

Health Care
Health Diagnostics
$92M07 Dec 2016 San Clemente, California, United States

Auregen BioTherapeutics

3D Technology
01 Dec 2016 Geneva, Geneva, Switzerland
Mahana Therapeutics Raises $61M in Series B Financing

– Mahana Therapeutics, a San Francisco, CA-based developer of prescription digital therapeutics designed to empower patients with chronic health conditions, raised $61m in Series B financing.
– The round was led by JAZZ Venture Partners and Gurnet Point Capital with participation from new and existing investors Main Street Advisors, KKCG and Lux Capital.
– The company will use the funds to launch the FDA-cleared prescription digital therapeutic Mahana™ IBS and accelerate development of several digital therapeutics for chronic health conditions.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Gurnet Point Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: